QTREX Quantum (QTEX) vs Sensus Healthcare (SRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
QTREX Quantum (QTEX) has outperformed Sensus Healthcare (SRTS) over the past year, gaining 9.3% versus a loss of 43.8%. Over five years, SRTS leads with a -63.5% price change compared with -69.7% for QTEX. QTREX Quantum is the larger company by market cap ($70.6 million vs $37.2 million), about 1.9 times the size.
Sensus Healthcare converts more of its revenue into profit, with a net margin of -28.1% versus -4574.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QTEX | SRTS |
|---|---|---|
| Share price | $1.00 | $2.26 |
| Market cap | $70.63M | $37.20M |
| 1-day change | -10.71% | -4.24% |
| YTD return | +11.11% | -43.22% |
| 1-year return | +9.29% | -43.78% |
| 5-year return | -69.70% | -63.55% |
| EPS (TTM) | $-0.35 | $-0.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $289.00K | $27.48M |
| Revenue growth (YoY) | — | -34.26% |
| Net income (latest FY) | $-13.22M | $-7.72M |
| Gross margin | 0.69% | 43.18% |
| Operating margin | -4713.84% | -37.50% |
| Net margin | -4574.39% | -28.09% |
| 52-week high | $3.85 | $5.49 |
| 52-week low | $0.283 | $2.14 |
| Distance from 52-week high | -74.03% | -58.83% |
| Analyst consensus | none | none |
| Avg. price target upside | +400.00% | +138.05% |
| Average volume | 9.21M | 208.74K |
| Shares outstanding | 70.63M | 16.46M |
| Employees | 34 | 60 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QTEX has outperformed SRTS by 53.1 percentage points over the past year.
- Sensus Healthcare is more profitable, keeping -28.1 cents of every revenue dollar as net income versus -4574.4 cents for QTREX Quantum.
About QTREX Quantum
QTEX stock →QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
Health Care · Medical/Dental Instruments · 34 employees
About Sensus Healthcare
SRTS stock →Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.
Health Care · Medical/Dental Instruments · 60 employees
QTEX vs SRTS FAQ
Which is bigger, QTREX Quantum or Sensus Healthcare?
QTREX Quantum (QTEX) is larger, with a market capitalization of $70.63M compared with $37.20M for Sensus Healthcare (SRTS).
Which stock has performed better over the past year, QTEX or SRTS?
QTEX returned +9.29% over the past 12 months, compared with -43.78% for SRTS (price return, excluding dividends). Past performance does not predict future results.
Are QTREX Quantum and Sensus Healthcare in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.